Over the past decade, the U.S. human embryonic stem cell (hESC) policy has become a hodgepodge of difficult-to-understand and easily misinterpreted legislation and regulations.
Oct. 12, 2007, 1 a.m.
Muzaffar Qazilbash, M.D., is a nonresident scholar for biomedical research policy in the Center for Health and Biosciences. He serves as professor of medicine and director of myeloma transplantation and cellular therapy in the Department of Stem Cell Transplantation at …
Christopher F. Kulesza, Ph.D., is a scholar for the Child Health Policy Program, where he carries out research in child and community health policy. His current research project focuses on the influences of built and social neighborhood environments on health …
September 09, 2022
Advances in biomedical research are often hailed for their potential in treating a variety of …
September 17, 2022
The Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine will host …
October 14, 2022
Vaccines are one of the most effective ways to reduce the spread of disease and …
